Doctor of Philosophy New York University
Masters of Science University of Belgrade
Bachelor of Science University of Belgrade
Excludes commercial-in-confidence projects.
Research since 2008 is shown below. To see earlier years visit Scopus
Open access indicates that an output is open access.
Allison, SE, Chen, Y, Petrovic, N, Zhang, J, Bourget, K, Mackenzie, P I & Murray, M 2017, 'Activation of ALDH1A1 in MDA-MB-468 breast cancer cells that over-express CYP2J2 protects against paclitaxel-dependent cell death mediated by reactive oxygen species', Biochemical Pharmacology, vol. 143, pp. 79-89.
Open access 9 10 1
Allison, SE, Chen, Y, Petrovic, N, Zimmermann, S, Moosmann, B, Jansch, M, Cui, PH, Dunstan, CR, Mackenzie, P I & Murray, M 2016, 'Activation of the pro-migratory bone morphogenetic protein receptor 1B gene in human MDA-MB-468 triple-negative breast cancer cells that over-express CYP2J2', The International Journal of Biochemistry and Cell Biology, vol. 80, no. 1, pp. 173-178.
Open access 27 27
Allison, SE, Petrovic, N, Mackenzie, PI & Murray, M 2015, 'Pro-migratory actions of the prostacyclin receptor in human breast cancer cells that over-express cyclooxygenase-2', Biochemical Pharmacology.
10 9 5
Goh, W, Sleptsova- Freidrich, I & Petrovic, N 2014, 'Use of proton pump inhibitors as adjunct treatment for triple-negative breast cancers. An introductory study', Journal of Pharmacy and Pharmaceutical Sciences, vol. 17, no. 3, pp. 439-446.
Open access 27 22
Cui, P, Rawling, T, Bourget, K, Kim, T, Duke, CC, Doddareddy, MR, Hibbs, DE, Zhou, F, Tattam, B, Petrovic, N & Murray, M 2012, 'Antiproliferative and antimigratory actions of synthetic long chain n-3 monounsaturated fatty acids in breast cancer cells that overexpress cyclooxygenase-2', Journal of Medicinal Chemistry, vol. 55, no. 16, pp. 7163-7172.
MISSO, N, Petrovic, N, Grove, C, Celenza, A, Brooks-Wildhaber, J & Thompson, P 2008, 'Plasma phospholipase A2 activity in patients with asthma: Association with body mass index and cholesterol concentration ', Thorax, vol. 63, no. 1, pp. 21-26.
Open access 16 16
Open access 92 87
Supervisions from 2010 shown
|Thesis title||Student status|
|Investigating the role of novel Tropomyosin receptor kinase (TRK) inhibitor for the treatment of NTRK fusion-positive lung cancer||Current|
|Investigating a novel CDK9 Inhibitor, CDKI-73, as a treatment for AML||Completed|